Subscribe To Our Free Newsletter |
Gland Pharma secures USFDA approval for Edaravone and Plerixafor injections
The shares were up by 0.42 per cent to ₹1,712.35 at 2.46 pm on the BSE
Subscribe To Our Free Newsletter |
EvoLve theme by Theme4Press • Powered by WordPress & Rakesh Jhunjhunwala Latest Stock Market News
The Most Valuable Commodity Is Information!